Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers

Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers - Exploratory study of activity after intake of foods containing SNR14 in healthy volunteers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042438

Enrollment

Registered

2020-11-13

Start date

2020-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer

Interventions

2-weeks intake of SNR14-containing food 2-weeks intake of the placebo food

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Subjects who have obtained written consent for participation in the research. 2)Healthy men and women aged between 20 and 60. 3)Subjects who can take test foods, etc., take blood samples, take urine samples, and stay quiet and rest on the schedule indicated by investigators.

Exclusion criteria

Exclusion criteria: 1)Subjects whose clinical inspection results are outside of the normal range and who are estimated inappropriate to this study. 2)Subjects who have or had disorder in digestive, circulatory or endocrine system and who are estimated inappropriate to this study. 3)As a general rule, those who regularly use drugs for the purpose of treating diseases. 4)Subjects who have allergy. 5)Lactating people, pregnant women or those who may be pregnant, and those who wish to become pregnant during the study period. 6)Subjects who are estimated inappropriate to this study by principal investigator or investigators.

Design outcomes

Primary

Measure	Time frame
Amount of activity (physical activity intensity (METs), number of steps, speed, time, location information (GPS))	—

Secondary

Measure	Time frame
(Exploratory measurement item) Heart rate, sleep quality (sleep score, sleep time, sleep interruption time), body composition (weight, body water content, muscle mass, body fat mass, body fat percentage, basal metabolic rate, visceral fat level), grip strength, health related QOL, weather , temperature, humidity (Safety evaluation) General physical findings (subjective symptoms, objective findings), vital signs (weight, body temperature, blood pressure, pulse rate), blood test items, urinalysis items, frequency of adverse events	—

Measure

Time frame

(Exploratory measurement item) Heart rate, sleep quality (sleep score, sleep time, sleep interruption time), body composition (weight, body water content, muscle mass, body fat mass, body fat percentage, basal metabolic rate, visceral fat level), grip strength, health related QOL, weather , temperature, humidity (Safety evaluation) General physical findings (subjective symptoms, objective findings), vital signs (weight, body temperature, blood pressure, pulse rate), blood test items, urinalysis items, frequency of adverse events

—

Countries

Japan

Contacts

Public ContactTsubasa Mizokami

Otsuka Pharmaceutical Co., Ltd. Saga Nutraceuticals Research Institute

Mizokami.Tsubasa@otsuka.jp0952-52-1522

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026